Authors:
VALJAKKAKOSKELA R
KIRJAVAINEN M
MONKKONEN J
URTTI A
KIESVAARA J
Citation: R. Valjakkakoskela et al., ENHANCEMENT OF PERCUTANEOUS-ABSORPTION OF NAPROXEN BY PHOSPHOLIPIDS, International journal of pharmaceutics, 175(2), 1998, pp. 225-230
Authors:
JAASKELAINEN I
STERNBERG B
MONKKONEN J
URTTI A
Citation: I. Jaaskelainen et al., PHYSICOCHEMICAL AND MORPHOLOGICAL PROPERTIES OF COMPLEXES MADE OF CATIONIC LIPOSOMES AND OLIGONUCLEOTIDES, International journal of pharmaceutics, 167(1-2), 1998, pp. 191-203
Citation: J. Monkkonen et A. Urtti, LIPID FUSION IN OLIGONUCLEOTIDE AND GENE DELIVERY WITH CATIONIC LIPIDS, Advanced drug delivery reviews, 34(1), 1998, pp. 37-49
Citation: J. Monkkonen et al., EFFECTS OF TILUDRONATE AND IBANDRONATE ON THE SECRETION OF PROINFLAMMATORY CYTOKINES AND NITRIC-OXIDE FROM MACROPHAGES IN-VITRO, Life sciences, 62(8), 1998, pp. 95-102
Authors:
AURIOLA S
FRITH J
ROGERS MJ
KOIVUNIEMI A
MONKKONEN J
Citation: S. Auriola et al., IDENTIFICATION OF ADENINE NUCLEOTIDE-CONTAINING METABOLITES OF BISPHOSPHONATE DRUGS USING ION-PAIR LIQUID CHROMATOGRAPHY-ELECTROSPRAY MASS-SPECTROMETRY, Journal of chromatography B. Biomedical sciences and applications, 704(1-2), 1997, pp. 187-195
Authors:
HIRVONEN MR
NEVALAINEN A
MAKKONEN N
MONKKONEN J
SAVOLAINEN K
Citation: Mr. Hirvonen et al., STREPTOMYCES SPORES FROM MOLDY HOUSES INDUCE NITRIC-OXIDE, TNF-ALPHA AND IL-6 SECRETION FROM RAW264.7 MACROPHAGE CELL-LINE WITHOUT CAUSING SUBSEQUENT CELL-DEATH, Environmental toxicology and pharmacology, 3(1), 1997, pp. 57-63
Citation: Jc. Frith et al., CLODRONATE AND LIPOSOME-ENCAPSULATED CLODRONATE ARE METABOLIZED TO A TOXIC ATP ANALOG, ADENOSINE 5'-(BETA,GAMMA-DICHLOROMETHYLENE) TRIPHOSPHATE, BY MAMMALIAN-CELLS IN-VITRO, Journal of bone and mineral research, 12(9), 1997, pp. 1358-1367
Authors:
ALAKANGAS A
SELANDER KS
HALLEEN J
MULARI M
LEHENKARI P
MONKKONEN J
VAANANEN HK
Citation: A. Alakangas et al., ALENDRONATE CHANGES THE ULTRASTRUCTURE OF OSTEOBLAST AND INHIBITS ITSACTIVITY WITHOUT CHANGING ITS LIFE-SPAN IN-VITRO, Journal of bone and mineral research, 12, 1997, pp. 469-469
Authors:
ROGERS MJ
XIONG XJ
JI XH
MONKKONEN J
RUSSELL RGG
WILLIAMSON MP
EBETINO FH
WATTS DJ
Citation: Mj. Rogers et al., INHIBITION OF GROWTH OF DICTYOSTELIUM-DISCOIDEUM AMEBAS BY BISPHOSPHONATE DRUGS IS DEPENDENT ON CELLULAR UPTAKE, Pharmaceutical research, 14(5), 1997, pp. 625-630
Citation: R. Ylitalo et al., EFFECTS OF LIPOSOME-ENCAPSULATED BISPHOSPHONATES ON ACETYLATED LDL METABOLISM, LIPID-ACCUMULATION AND VIABILITY OF PHAGOCYTING CELLS, Life sciences, 62(5), 1997, pp. 413-422
Authors:
VANGELDER JM
BREUER E
SCHLOSSMAN A
ORNOY A
MONKKONEN J
SIMILA J
KLENNER T
STADLER H
KREMPIEN B
PATLAS N
GOLOMB G
Citation: Jm. Vangelder et al., IN-VITRO AND IN-VIVO EFFECTS OF TETRAKISPHOSPHONATES ON BONE-RESORPTION, TUMOR OSTEOLYSIS, ECTOPIC CALCIFICATION, AND MACROPHAGES, Journal of pharmaceutical sciences, 86(3), 1997, pp. 283-289
Authors:
HIRVONEN MR
NEVALAINEN A
MAKKONEN N
MONKKONEN J
SAVOLAINEN K
Citation: Mr. Hirvonen et al., INDUCED PRODUCTION OF NITRIC-OXIDE, TUMOR-NECROSIS-FACTOR, AND INTERLEUKIN-6 IN RAW-264.7 MACROPHAGES BY STREPTOMYCETES FROM INDOOR AIR OF MOLDY HOUSES, Archives of environmental health, 52(6), 1997, pp. 426-432
Authors:
FRITH JC
MONKKONEN J
RUSSELL RGG
BLACKBURN GM
WATTS DJ
ROGERS MJ
Citation: Jc. Frith et al., CLODRONATE AND LIPOSOME-ENCAPSULATED CLODRONATE CAN BE METABOLIZED INA NONHYDROLYZABLE ATP ANALOG BY MAMMALIAN-CELLS IN-VITRO, Journal of bone and mineral research, 11(11), 1996, pp. 8-8
Authors:
SELANDER KS
MONKKONEN J
KARHUKORPI EK
HARKONEN P
HANNUNIEMI R
VAANANEN HK
Citation: Ks. Selander et al., CHARACTERISTICS OF CLODRONATE-INDUCED APOPTOSIS IN OSTEOCLASTS AND MACROPHAGES, Molecular pharmacology, 50(5), 1996, pp. 1127-1138
Authors:
MAKKONEN N
HIRVONEN MR
TERAVAINEN T
SAVOLAINEN K
MONKKONEN J
Citation: N. Makkonen et al., DIFFERENT EFFECTS OF 3 BISPHOSPHONATES ON NITRIC-OXIDE PRODUCTION BY RAW-264 MACROPHAGE-LIKE CELLS IN-VITRO, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 1097-1102
Citation: R. Ylitalo et al., ACCUMULATION OF BISPHOSPHONATES IN THE AORTA AND SOME OTHER TISSUES OF HEALTHY AND ATHEROSCLEROTIC RABBITS, The Journal of laboratory and clinical medicine, 127(2), 1996, pp. 200-206
Authors:
KIRJAVAINEN M
URTTI A
JAASKELAINEN I
SUHONEN TM
PARONEN P
VALJAKKAKOSKELA R
KIESVAARA J
MONKKONEN J
Citation: M. Kirjavainen et al., INTERACTION OF LIPOSOMES WITH HUMAN SKIN IN-VITRO - THE INFLUENCE OF LIPID-COMPOSITION AND STRUCTURE, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1304(3), 1996, pp. 179-189
Authors:
MAKKONEN N
HIRVONEN MR
SAVOLAINEN K
LAPINJOKI S
MONKKONEN J
Citation: N. Makkonen et al., THE EFFECT OF FREE GALLIUM AND GALLIUM IN LIPOSOMES ON CYTOKINE AND NITRIC-OXIDE SECRETION FROM MACROPHAGE-LIKE CELLS IN-VITRO, Inflammation research, 44(12), 1995, pp. 523-528
Authors:
PENNANEN N
LAPINJOKI S
URTTI A
MONKKONEN J
Citation: N. Pennanen et al., EFFECT OF LIPOSOMAL AND FREE BISPHOSPHONATES ON THE IL-1-BETA, 1L-6 AND TNF-ALPHA SECRETION FROM RAW-264 CELLS IN-VITRO, Pharmaceutical research, 12(6), 1995, pp. 916-922
Authors:
PENNANEN N
LAPINJOKI S
PALANDER A
URTTI A
MONKKONEN J
Citation: N. Pennanen et al., MACROPHAGE-LIKE RAW-264 CELL-LINE AND TIME-RESOLVED FLUOROIMMUNOASSAY(TRFIA) AS TOOLS IN SCREENING DRUG EFFECTS ON CYTOKINE SECRETION, International journal of immunopharmacology, 17(6), 1995, pp. 475-480
Authors:
MONKKONEN J
LIUKKONEN J
TASKINEN M
HEATH TD
URTTI A
Citation: J. Monkkonen et al., STUDIES ON LIPOSOME FORMULATIONS FOR INTRAARTICULAR DELIVERY OF CLODRONATE, Journal of controlled release, 35(2-3), 1995, pp. 145-154
Authors:
MONKKONEN J
TASKINEN M
AURIOLA SOK
URTTI A
Citation: J. Monkkonen et al., GROWTH-INHIBITION OF MACROPHAGE-LIKE AND OTHER CELL-TYPES BY LIPOSOME-ENCAPSULATED, CALCIUM-BOUND, AND FREE BISPHOSPHONATES IN-VITRO, Journal of drug targeting., 2(4), 1994, pp. 299-308
Authors:
MONKKONEN J
VALJAKKA R
HAKASALO M
URTTI A
Citation: J. Monkkonen et al., THE EFFECTS OF LIPOSOME SURFACE-CHARGE AND SIZE ON THE INTRACELLULAR DELIVERY OF CLODRONATE AND GALLIUM IN-VITRO, International journal of pharmaceutics, 107(3), 1994, pp. 189-197